Table 3.

SETBP1 mutations in atypical CML and unclassifiable MDS/MPN

	Reference	Number of Patients	Mutation Prevalence	Impact on Survival
Atypical CML	[34]	70	17 (24.3%)	Yes (p-0.01)
	[32]	60	19 (32.1%)	No (p-0.191)
Unclassifiable MDS/MPN	[34]	30	3 (10%)	NR
	[32]	240	20 (9.3%)	NR

NR Not reported